Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07689773 · ClinicalTrials.gov registry record · Phase 2
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label
A Phase 2 study, sponsored by Medical University of South Carolina.
- Not yet
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT07689773 is a Phase 2 study that has not yet begun recruiting, run by Medical University of South Carolina. The registered enrollment target is 60 participants.
The verdict
NCT07689773, a Phase 2 study, has not yet begun recruiting, sponsored by Medical University of South Carolina.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Smell dysfunction significantly impacts quality of life and safety, with limited effective treatments. This open-label study evaluates the preliminary efficacy of combining non-invasive trigeminal nerve stimulation (TNS) with standard smell training (ST) to improve olfactory function. Participants will complete 8 weeks of at-home treatment and attend three in-person visits for assessment. Improvements in smell, mood, sleep, and quality of life will be measured.
Interventions
- COMBINATION_PRODUCT Trigeminal Nerve Stimulation-enhanced Smell Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-07-08 |
| Est. Completion | 2028-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07689773
The ClinicalTrials.gov registry entry for NCT07689773 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trigeminal Nerve Stimulation-enhanced Smell Training is the first listed.
NCT07689773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07689773 about?
NCT07689773 is a clinical study titled "Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label". Smell dysfunction significantly impacts quality of life and safety, with limited effective treatments. This open-label study evaluates the preliminary efficacy of combining non-invasive trigeminal nerve stimulation (TNS) with standard smell training (ST) to improve olfactory function. Participants w...
What is the current status of trial NCT07689773?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2026-07-08. Estimated completion is 2028-06-30.
What interventions are being tested in trial NCT07689773?
The interventions under investigation include: Trigeminal Nerve Stimulation-enhanced Smell Training (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07689773?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.